Diclofenac Potassium + Paracetamol + SerratiopeptidaseThird Party Manufacturing in India

Diclofenac Potassium + Paracetamol + Serratiopeptidase works by matching anti-inflammatory analgesia with enzymatic tissue debridement. Diclofenac and paracetamol block systemic prostaglandin synthesis, while serratiopeptidase hydrolyzes inflammatory exudates and bradykinin. It clears cellular debris and fluid accumulation to help the body accelerate edema resolution and tissue repair. Unlike non-enzymatic combinations, it directly cuts down swelling and improves antibiotic tissue penetration. It is highly effective and well-tolerated.

Therapeutic Uses

• Post-Traumatic Edema: It resolves painful fluid swelling following fractures, athletic injuries, or accidental impact bruises.
• Surgical Incision Healing: It minimizes post-operative wound inflammation and localized cellular edema.
• Severe ENT Inflammation: It relieves painful swelling in acute tonsillitis, sinusitis, and otitis conditions.

Why Manufacturers Choose Diclofenac Potassium + Paracetamol + Serratiopeptidase

Enzyme-linked analgesics are highly preferred by surgeons and specialists for rapid post-operative recovery. Sourcing Diclofenac Potassium + Paracetamol + Serratiopeptidase third party manufacturing in India ensures access to enteric-coating expertise required to protect sensitive enzymes. Our partner facilities maintain strict climate controls where our production facilities are WHO-GMP certified to preserve enzyme activity values.